To improve the website's functionality, we use cookies, including third-party cookies. Read our Privacy Policy for more information
I AgreeAnalysis of Vertebroplasty and Kyphoplasty Needles market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Valued at US$ 829 Million in 2021, the vertebroplasty and kyphoplasty needles market is expected to take a turn for the better to reach US$ 874 Million by 2022, reflecting a Y-o-Y growth rate of 5.4%. During the 2022-2032 forecast period, sales of vertebroplasty and kyphoplasty needles are expected to flourish at a 4.8% CAGR, reaching US$ 1.4 Billion.
The market is expected to show a remarkable growth in the forecast period owing to the rise in the incidence of spinal injuries as a result of car accidents and sports injuries. Moreover, the rapidly increasing geriatric population suffering from osteoporosis is boosting the market for vertebroplasty and kyphoplasty needles.
Report Attributes |
Details |
---|---|
Anticipated Base Year Value (2021) |
US$ 829 Million |
Projected Current Market Value (2022) |
US$ 874 Million |
Expected Forecast Value (2032) |
US$ 1.4 Billion |
Growth Rate (2022-2032) |
4.8% CAGR |
Expected Market Value of the U.S (2032) |
US$ 499 Million |
Anticipated Growth Rate of China (2022-2032) |
4.3% CAGR |
Key Companies Profiled |
|
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Rising Incidence of Minimally invasive Surgical Procedures for Various Chronic Ailments
Because of the surge in popularity of minimally invasive surgical procedures and technological breakthroughs in the healthcare sector, the vertebroplasty and kyphoplasty needles market is expected to grow during the forecast period of 2022-2032.
Bone cement is injected into the vertebra to support the specific broken bone during vertebroplasty. Kyphoplasty is a modified version of vertebroplasty in which a balloon tamp is inflated in the vertebral area to compress and form a cavity in the cancellers’ bone.
Rising cases of vertebral fractures in the young population as a result of high-velocity injuries while exercising or performing other activities are positively impacting the vertebroplasty and kyphoplasty needles market.
The vertebroplasty and kyphoplasty needles market is benefiting greatly from advances in image-guided surgical procedures. Innovations and new technology development based on research activities conducted by manufacturers in the vertebroplasty and kyphoplasty needles market are proving to be growth generators for the vertebroplasty and kyphoplasty needles market.
Frequent mergers and acquisitions may have a positive impact on the vertebroplasty and kyphoplasty needles market growth rate.
The main factor impeding the growth of the vertebroplasty and kyphoplasty needles market, such as high surgical costs as well as the presence of alternative devices. Moreover, the overall complication rate of vertebroplasty and kyphoplasty is low, ranging from 2% when treating osteoporotic compression fractures to 10% when treating malignant tumors [30, 39, 52, and 53].
Extravasation of the cement into the epidural space causes more serious complications with vertebroplasty and kyphoplasty. Although vertebroplasty is widely regarded as a relatively safe procedure for relieving pain caused by a vertebral compression fracture, it is still surgery and carries some risks. Henceforth, all these factors are anticipated to hamper the market growth during the forecast period.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Attributes |
Vertebroplasty and Kyphoplasty Needles Market |
CAGR (2022-2032) |
4.8% |
Market Value (2032) |
US$ 1.4 Billion |
Growth Factor |
Increasing prevalence of back injuries is anticipated to propel the market growth significantly. |
Opportunity |
Technological advancements in health care sector are expected to offer remunerative opportunities for market growth. |
Attributes |
Chronic Lower Back Pain Market |
CAGR (2022-2032) |
4.7% |
Market Value (2032) |
US$ 11 Billion |
Growth Factor |
During the forecast period, the major growth drivers for the Chronic Lower Back Pain Market are an increase in the emergence of nerve cases and an increase in the geriatric population. |
Opportunity |
Inactive lifestyles, rising healthcare awareness in developed and developing countries, and rising disposable income of consumers are expected to support market growth in the assessment period. |
Attributes |
Spinal Devices Market |
CAGR (2022-2032) |
3.5% |
Market Value (2032) |
US$ 20 Billion |
Growth Factor |
The global market for spinal devices is expected to be driven by technological advancements, an increase in the number of spinal surgeries and population ageing. |
Opportunity |
Growing use of spinal devices in geriatric as well as arthritis patients are expected to offer positive growth prospects for the global spinal device market during the forecast period. |
According to Fact.MR’s analysis, the global vertebroplasty and kyphoplasty needles expected to be dominated by the U.S during the forecast period. The evaluation states that the U.S market is predicted to secure a market value of US$ 499 Million while growing at a CAGR of 4.6% during the forecast period from 2022 to 2032.
The country is forecast to maintain its dominant growth trajectory throughout the forecast period, owing to rising adoption of technologically advanced products and the high prevalence of orthopedic disorders. In 2019, North America dominated the market, accounting for more than 35.6% of global revenue. This is due to an increase in the prevalence of osteoporosis in this region, as well as an elevated preference for minimally invasive surgery to treat VCFs.
As per the analysis, the Asia Pacific vertebroplasty and kyphoplasty needles market is expected to expand at a relatively high rate during the forecast period, owing to an increased focus on the development of health care infrastructure by both public and private hospitals, as well as an increase in demand for affordable care from a significant patient population.
Out of all countries in Asia Pacific, China is expected to emerge as the strongest market, accelerating at a 4.3% value CAGR from 2022 to 2032. Fact.MR further estimates that the country will likely yield an absolute dollar growth worth US$ 35 Million until 2032, being valued at US$ 102 Million. As of 2022, sales of vertebroplasty and kyphoplasty needles in China are expected to be valued at US$ 67 Million.
Across China, the emphasis on conservative treatment to prevent onset of possible side effects for a variety of diseases has always acquired precedence. At present, clinical trials have concluded that external treatment through Traditional Chinese Medicine, such as acupuncture and acupoint application are highly effective in treating thoracolumbar compression fractures. Hence, demand for vertebroplasty and kyphoplasty needles is rising.
Country |
Estimated CAGR |
---|---|
U.S |
4.6% |
U.K |
3.8% |
China |
4.3% |
Japan |
3.5% |
South Korea |
2.4% |
Hospitals to Generate Maximum Demand for Vertebroplasty and Kyphoplasty Needles
Based on end use, hospitals are projected to generate maximum vertebroplasty and kyphoplasty needles demand. As per the analysis, the segment is anticipated to expand at a CAGR of 4.3% during the forecast period from 2022 to 2032.
It is estimated that vertebral compression fractures account for approximately 70,000 hospitalizations each year, especially across countries such as the U.S, thus promoting the growth of the market for vertebroplasty and kyphoplasty needles.
Kyphoplasty Procedures to account for Bulk of all Needles Sales through 2032
According to Fact.MR’s projections, kyphoplasty procedure needles are expected to generate maximum revenue, anticipated to flourish at a CAGR of 4.4% during the 2022-2032 forecast period. Given the high incidence rate of osteoporosis, which lead to 8.9 Million fractures worldwide, most patients are advised to undergo kyphoplasty surgery.
In many cases, vertebral compression fractures result in a kyphosis of the affected vertebral body. Any increase in kyphosis inevitably shifts the center of gravity ventrally. This changes the weight force distribution of remaining vertebral bodies, increasing the possibility of multiple fractures.
Don't Need a Global Report?
Save 40% on Country & Region specific reports
As there are varying demands based on utilization, key market manufacturers have been emphasizing more on research and development activities as well as producing innovative product solutions for specific applications. Leading market players have identified how improved accuracy can have a significant impact in a variety of applications.
Market participants in the vertebroplasty and kyphoplasty markets are focused on investing in research and development to develop newer devices with improved technology that would allow surgeons to perform the procedure with ease and improve patient healing. This would help industries improve their market positions. Some of the recent developments in the global vertebroplasty and kyphoplasty needles market are:
- Premium Report Details -
- Let's Connect -
- Quick Contact -
- Get Started -
Get insights that lead to new growth opportunities
Buy NowGet A Special pricing for start-ups and universities
Enquiry Before Buying- Humble, Yet Honored -
- Related Reports -
The vertebroplasty and kyphoplasty needles market is estimated to reach US$ 1.4 Billion by 2032
According to Fact.MR, the vertebroplasty and kyphoplasty needles market in the U.S is expected to reach US$ 499 Million by 2032
The global vertebroplasty and kyphoplasty needles market is estimated at US$ 829 Million in 2021.
China is anticipated to grow at 4.3% CAGR during the forecast period.
The kyphoplasty procedures segment is predicted to lead the market with a CAGR of 4.4% during the assessment period.